Kiromic BioPharma, Inc. (KRBP)
OTCMKTS
· Delayed Price · Currency is USD
1.615
-0.315 (-16.32%)
Feb 20, 2025, 3:00 PM EST
Kiromic BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | -26.9 | -20.95 | -34.73 | -25.59 | -19.2 | Upgrade
|
| Depreciation & Amortization | 2.23 | 2.22 | 1.67 | 0.47 | 0.2 | Upgrade
|
| Other Amortization | - | - | 0.01 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.01 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.43 | - | Upgrade
|
| Stock-Based Compensation | 0.6 | 0.14 | 1.24 | 3.76 | 13.25 | Upgrade
|
| Other Operating Activities | 4.41 | 2.37 | 3.71 | -0.11 | 0.02 | Upgrade
|
| Change in Accounts Receivable | - | - | 0.02 | 0.01 | - | Upgrade
|
| Change in Accounts Payable | 0.54 | -5.04 | 3.79 | 1.41 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.34 | 0.03 | 0.56 | -0.71 | -0.39 | Upgrade
|
| Operating Cash Flow | -19.46 | -21.23 | -23.75 | -20.32 | -6.13 | Upgrade
|
| Capital Expenditures | -0.37 | -0.21 | -4.88 | -1.89 | -1.46 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.02 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | 0.08 | - | Upgrade
|
| Investing Cash Flow | -0.37 | -0.21 | -4.87 | -1.81 | -1.46 | Upgrade
|
| Short-Term Debt Issued | 18.9 | 24 | 4.61 | 0.67 | 0.66 | Upgrade
|
| Total Debt Issued | 18.9 | 24 | 4.61 | 0.67 | 0.66 | Upgrade
|
| Short-Term Debt Repaid | -0.49 | -0.56 | -0.51 | -0.57 | -0.19 | Upgrade
|
| Total Debt Repaid | -0.49 | -0.56 | -0.51 | -0.57 | -0.19 | Upgrade
|
| Net Debt Issued (Repaid) | 18.42 | 23.44 | 4.1 | 0.09 | 0.47 | Upgrade
|
| Issuance of Common Stock | - | 0.66 | - | 40.13 | 15 | Upgrade
|
| Other Financing Activities | - | -0.11 | -0.2 | -2.88 | -2.67 | Upgrade
|
| Financing Cash Flow | 18.42 | 23.99 | 3.9 | 37.34 | 15.81 | Upgrade
|
| Net Cash Flow | -1.41 | 2.56 | -24.71 | 15.2 | 8.22 | Upgrade
|
| Free Cash Flow | -19.82 | -21.43 | -28.63 | -22.22 | -7.58 | Upgrade
|
| Free Cash Flow Per Share | -13.57 | -19.53 | -52.58 | -58.38 | -50.50 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.06 | 0.01 | 0.01 | 0 | Upgrade
|
| Levered Free Cash Flow | -14.84 | -14.23 | -15.69 | -12.66 | 5.7 | Upgrade
|
| Unlevered Free Cash Flow | -12.51 | -13.07 | -15.6 | -12.65 | 5.7 | Upgrade
|
| Change in Net Working Capital | 0.12 | 2.77 | -6.05 | -0.83 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.